AKRO vs. QQQ

Last updated Apr 1, 2026

Compare and contrast key facts about Akero Therapeutics, Inc. (AKRO) and Invesco QQQ ETF (QQQ).

QQQ is a passively managed fund by Invesco that tracks the performance of the NASDAQ-100 Index. It was launched on Mar 10, 1999.

Performance

AKRO vs. QQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Akero Therapeutics, Inc. (AKRO) and Invesco QQQ ETF (QQQ). The values are adjusted to include any dividend payments, if applicable.

AKRO vs. QQQ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
AKRO Akero Therapeutics, Inc.	0.00%	96.44%	19.14%	-57.39%	159.10%	-18.02%	16.24%	21.15%
QQQ Invesco QQQ ETF	-4.76%	20.77%	25.58%	54.86%	-32.58%	27.42%	48.62%	13.30%

Returns By Period

AKRO

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

QQQ

• 1D: 1.24%
• 1M: -3.79%
• YTD: -4.76%
• 6M: -2.89%
• 1Y: 24.21%
• 3Y*: 22.83%
• 5Y*: 13.16%
• 10Y*: 18.99%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

AKRO vs. QQQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QQQ

QQQ Risk / Return Rank: 65
QQQ Sharpe Ratio Rank: 58
QQQ Sortino Ratio Rank: 63
QQQ Omega Ratio Rank: 63
QQQ Calmar Ratio Rank: 74
QQQ Martin Ratio Rank: 69

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AKRO vs. QQQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Akero Therapeutics, Inc. (AKRO) and Invesco QQQ ETF (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	AKRO	QQQ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.07	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.59	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.86	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.38	—

Correlation

The correlation between AKRO and QQQ is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

AKRO vs. QQQ - Dividend Comparison

AKRO has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.48%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AKRO Akero Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
QQQ Invesco QQQ ETF	0.48%	0.45%	0.56%	0.62%	0.80%	0.43%	0.55%	0.74%	0.91%	0.84%	1.06%	0.99%

Drawdowns

Drawdown Indicators

	AKRO	QQQ	Difference
Max Drawdown Largest peak-to-trough decline	—	-82.97%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-12.62%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-35.12%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-35.12%	—
Current Drawdown Current decline from peak	—	-7.86%	—
Average Drawdown Average peak-to-trough decline	—	-32.99%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	3.44%	—

Volatility

Volatility by Period

	AKRO	QQQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	6.61%	—
Volatility (6M) Calculated over the trailing 6-month period	—	12.82%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	22.70%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	22.38%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	22.25%	—